Showing results (21-30 of 8,127) with videos related to
Sort By:
Pageof 813
Journal of Inorganic Biochemistry|September 24, 2015
Folate-functionalized human serum albumin carrier for anticancer copper(II) complexes derived from natural plumbaginYi Gou, Zhan Zhang, Jinxu Qi, et al.Dalton Transactions (Cambridge, England : 2003)|April 12, 2023
Development of a zinc(II) 2-pyridinecarboxaldehyde thiosemicarbazone complex with remarkable antitumor and antiangiogenic activitiesMing Jiang, Jinhui Pang, Xiaoying Jia, et al.Journal of Medicinal Chemistry|April 18, 2023
Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum AlbuminZhenlei Zhang, Juzheng Zhang, Tongfu Yang, et al.Journal of Medicinal Chemistry|July 5, 2022
Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung CancerMing Jiang, Zhenlei Zhang, Wenjuan Li, et al.Organic Letters|February 10, 2022
Palladium-Catalyzed Enantioselective C(sp3)-H Arylation of 2-Propyl Azaaryls Enabled by an Amino Acid LigandHong-Liang Li, Deng-Feng Yang, Hua-Qing Jing, et al.Journal of Inorganic Biochemistry|December 10, 2020
Designing biotin-human serum albumin nanoparticles to enhance the targeting ability of binuclear ruthenium(III) compoundMing Jiang, Shanhe Li, Junmiao Wu, et al.Molecular Pharmaceutics|March 29, 2016
Developing an Anticancer Copper(II) Pro-Drug Based on the His242 Residue of the Human Serum Albumin Carrier IIA SubdomainJinxu Qi, Yao Zhang, Yi Gou, et al.Journal of Medicinal Chemistry|March 24, 2022
Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and TherapyZhenlei Zhang, Tongfu Yang, Juzheng Zhang, et al.Journal of Medicinal Chemistry|August 15, 2024
Rational Design of a Hetero-multinuclear Gadolinium(III)-Copper(II) Complex: Integrating Magnetic Resonance Imaging, Photoacoustic Imaging, Mild Photothermal Therapy, Chemotherapy and Immunotherapy of CancerXueyu Man, Wenjuan Li, Minghui Zhu, et al.Journal of Medicinal Chemistry|March 5, 2024
Designing a Mitochondria-Targeted Theranostic Cyclometalated Iridium(III) Complex: Overcoming Cisplatin Resistance and Inhibiting Tumor Metastasis through Necroptosis and Immune ResponseWenjuan Li, Ting Li, Ying Pan, et al.Pageof 813